Advertisement
Screener

PACIRA BIOSCIENCES, INC. (PCRX) Gain (Loss) on Extinguishment of Debt

PACIRA BIOSCIENCES, INC. Gain (Loss) on Extinguishment of Debt

PACIRA BIOSCIENCES, INC. (PCRX) reported Gain (Loss) on Extinguishment of Debt of -$983.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-26

  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was -$983.00K.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $0.00.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$983.00K, a 113.08% decline from fiscal 2024.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $7.52M.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2023 was -$16.93M.
  • PACIRA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
Period endGain (Loss) on Extinguishment of Debt 1 monthGain (Loss) on Extinguishment of Debt 3 monthGain (Loss) on Extinguishment of Debt 6 monthGain (Loss) on Extinguishment of Debt 9 monthGain (Loss) on Extinguishment of Debt 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$983.00K
derived: sum of 2 quarters · filed 2026-02-26
-$983.00K
derived: sum of 3 quarters · filed 2026-02-26
-$983.00K
10-K · filed 2026-02-26
2025-09-30-$983.00K
10-Q · filed 2025-11-06
-$983.00K
derived: sum of 2 quarters · filed 2025-11-06
-$983.00K
10-Q · filed 2025-11-06
-$983.00K
derived: sum of 4 quarters · filed 2026-02-26
2025-06-30$0.00
10-Q · filed 2025-08-05
$0.00
10-Q · filed 2025-08-05
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2025-03-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$7.52M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$7.52M
derived: sum of 3 quarters · filed 2026-02-26
$7.52M
10-K · filed 2026-02-26
2024-09-30$0.00
10-Q · filed 2025-11-06
$7.52M
derived: sum of 2 quarters · filed 2025-11-06
$7.52M
10-Q · filed 2025-11-06
$7.52M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$7.52M
10-Q · filed 2025-08-05
$7.52M
10-Q · filed 2025-08-05
$7.52M
derived: sum of 3 quarters · filed 2026-02-26
$7.52M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$0.00
10-Q · filed 2024-05-07
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
-$16.93M
10-K · filed 2026-02-26
2023-09-30$0.00
10-Q · filed 2024-11-06
$0.00
derived: sum of 2 quarters · filed 2024-11-06
-$16.93M
10-Q · filed 2024-11-06
-$16.93M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$0.00
10-Q · filed 2024-07-30
-$16.93M
10-Q · filed 2024-07-30
-$16.93M
derived: sum of 3 quarters · filed 2025-02-27
-$16.93M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$16.93M
10-Q · filed 2024-05-07
-$16.93M
derived: sum of 2 quarters · filed 2025-02-27
-$16.93M
derived: sum of 3 quarters · filed 2025-02-27
-$16.93M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$0.00
derived: sum of 2 quarters · filed 2025-02-27
$0.00
derived: sum of 3 quarters · filed 2025-02-27
$0.00
10-K · filed 2025-02-27
2022-09-30$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$0.00
10-Q · filed 2023-08-02
$0.00
10-Q · filed 2023-08-02
$0.00
derived: sum of 3 quarters · filed 2024-02-29
$0.00
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$0.00
10-Q · filed 2023-05-03
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
derived: sum of 3 quarters · filed 2024-02-29
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
10-K · filed 2024-02-29
2021-09-30$0.00
10-Q · filed 2021-11-03
$0.00
10-Q · filed 2021-11-03
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$8.07M
derived: sum of 2 quarters · filed 2023-02-28
-$8.07M
10-K · filed 2023-02-28
2020-09-30-$8.07M
10-Q · filed 2021-11-03
-$8.07M
10-Q · filed 2021-11-03
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$0.00
derived: sum of 2 quarters · filed 2022-02-28
$0.00
10-K · filed 2022-02-28
2019-09-30$0.00
10-Q · filed 2020-10-30
$0.00
10-Q · filed 2020-10-30
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$0.00
derived: sum of 2 quarters · filed 2021-03-01
$0.00
derived: sum of 3 quarters · filed 2021-03-01
$0.00
10-K · filed 2021-03-01
2018-09-30$0.00
10-Q · filed 2018-11-01
$0.00
derived: sum of 2 quarters · filed 2018-11-01
$0.00
10-Q · filed 2018-11-01
$0.00
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$0.00
10-Q · filed 2018-08-02
$0.00
10-Q · filed 2018-08-02
$0.00
derived: sum of 3 quarters · filed 2020-02-21
$0.00
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$0.00
10-Q · filed 2018-05-03
$0.00
derived: sum of 2 quarters · filed 2020-02-21
$0.00
derived: sum of 3 quarters · filed 2020-02-21
-$11.00K
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$0.00
derived: sum of 2 quarters · filed 2020-02-21
-$11.00K
derived: sum of 3 quarters · filed 2020-02-21
-$3.73M
10-K · filed 2020-02-21
2017-09-30$0.00
10-Q · filed 2018-11-01
-$11.00K
derived: sum of 2 quarters · filed 2018-11-01
-$3.73M
10-Q · filed 2018-11-01
-$3.73M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$11.00K
10-Q · filed 2018-08-02
-$3.73M
10-Q · filed 2018-08-02
-$3.73M
derived: sum of 3 quarters · filed 2019-02-28
-$3.73M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$3.70M
10-Q · filed 2018-11-01
-$3.72M
10-Q · filed 2018-05-03
-$3.72M
derived: sum of 2 quarters · filed 2019-02-28
-$3.72M
derived: sum of 3 quarters · filed 2019-02-28
-$3.72M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$0.00
derived: sum of 2 quarters · filed 2019-02-28
$0.00
derived: sum of 3 quarters · filed 2019-02-28
$0.00
10-K · filed 2019-02-28
2016-09-30$0.00
10-Q · filed 2017-11-08
$0.00
derived: sum of 2 quarters · filed 2017-11-08
$0.00
10-Q · filed 2017-11-08
-$1.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$0.00
10-Q · filed 2017-08-02
$0.00
10-Q · filed 2017-08-02
-$1.00K
derived: sum of 3 quarters · filed 2018-02-28
-$1.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$0.00
10-Q · filed 2017-05-04
-$1.00K
derived: sum of 2 quarters · filed 2018-02-28
-$1.00K
derived: sum of 3 quarters · filed 2018-02-28
-$52.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
-$1.00K
derived: sum of 2 quarters · filed 2018-02-28
-$52.00K
derived: sum of 3 quarters · filed 2018-02-28
-$52.00K
10-K · filed 2018-02-28
2015-09-30$0.00
10-Q · filed 2016-11-02
-$51.00K
derived: sum of 2 quarters · filed 2016-11-02
-$51.00K
10-Q · filed 2016-11-02
2015-06-30-$51.00K
10-Q · filed 2016-08-04
-$51.00K
10-Q · filed 2016-08-04
2014-12-31$0.00
10-K · filed 2017-03-01
$0.00
derived: sum of 2 quarters · filed 2017-03-01
$0.00
derived: sum of 3 quarters · filed 2017-03-01
$0.00
10-K · filed 2015-02-24
2014-09-30$0.00
10-Q · filed 2015-10-27
$0.00
derived: sum of 2 quarters · filed 2015-10-27
$0.00
10-Q · filed 2015-10-27
$0.00
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$0.00
10-Q · filed 2015-07-30
$0.00
10-Q · filed 2015-07-30
$0.00
derived: sum of 3 quarters · filed 2016-02-25
$0.00
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$0.00
10-Q · filed 2014-05-01
$0.00
derived: sum of 2 quarters · filed 2016-02-25
$0.00
derived: sum of 3 quarters · filed 2016-02-25
$0.00
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$0.00
derived: sum of 2 quarters · filed 2016-02-25
$0.00
derived: sum of 3 quarters · filed 2016-02-25
-$3.40M
10-K · filed 2016-02-25
2013-09-30$0.00
10-Q · filed 2014-10-30
$0.00
derived: sum of 2 quarters · filed 2014-10-30
-$3.40M
10-Q · filed 2014-10-30
-$3.40M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$0.00
10-Q · filed 2014-07-31
-$3.40M
10-Q · filed 2014-07-31
-$3.40M
derived: sum of 3 quarters · filed 2015-02-24
-$3.40M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$3.40M
10-Q · filed 2014-05-01
-$3.40M
derived: sum of 2 quarters · filed 2015-02-24
-$3.40M
derived: sum of 3 quarters · filed 2015-02-24
-$4.46M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$0.00
derived: sum of 2 quarters · filed 2015-02-24
-$1.06M
derived: sum of 3 quarters · filed 2015-02-24
-$1.06M
10-K · filed 2015-02-24
2012-09-30$0.00
10-Q · filed 2013-10-31
-$1.06M
derived: sum of 2 quarters · filed 2013-10-31
-$1.06M
10-Q · filed 2013-10-31
2012-06-30-$1.06M
10-Q · filed 2013-08-06
-$1.06M
10-Q · filed 2013-08-06
2011-12-31$0.00
10-K · filed 2014-02-25
2010-12-31-$184.00K
10-K · filed 2013-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93